title: [Prevention of post intravitreal injection endophthalmitis: is antibioprophylaxis indicated?].
abstract: Endophthalmitis remains the main complication of intravitreal injections, especially because their repetition multiplicates the risks. Surgical antisepsis is required for the prevention of endophthalmitis, but the benefit/risk ratio of topical antibioprophylaxis has never been demonstrated. In contrast, the selection of resistant bacteria appears to be exponential with the wider use of topical antibioprophylaxis. It seems that more and more operators stop using anibioprophylaxis, provided that the antisepsis is surgical and that the injection is performed in accordance with the rules of good practice.
authors.affiliation: UMR-S 976, université Paris-Diderot, Sorbonne Paris-Cité, CHU Bichat-Fondation Rothschild, 25, rue Manin, 75019 Paris cedex 10, France. icochereau@fo-rothschild.fr
authors.forename: I
authors.initials: I
authors.lastname: Cochereau
authors.forename: J-F
authors.initials: JF
authors.lastname: Korobelnik
authors.forename: B
authors.initials: B
authors.lastname: Bodaghi
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D009877:Endophthalmitis / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D058449:Intravitreal Injections / Q000009:adverse effects*; D011182:Postoperative Care / Q000379:methods; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control; D011364:Professional Practice / Q000706:statistics & numerical data; D018570:Risk Assessment
chemical_list: D000900:Anti-Bacterial Agents